secwatch / observer
8-K filed August 16, 2022, 7:59 PM ET ticker VNRX CIK 0000093314
leadership confidence high sentiment neutral materiality 0.30

VolitionRx appoints Mickie Henshall as independent director effective Aug 15, 2022

VOLITIONRX LTD

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Mickie Henshall

Director
VNRX · VOLITIONRX LTD
Effective
2022-08-15
Filed
August 16, 2022, 7:59 PM ET
On August 15, 2022, the Board of Directors (the “ Board ”) of VolitionRx Limited (the “ Company ”), pursuant to the Company’s Bylaws, passed a resolution to increase the size of the Board to nine (9) members and appointed Ms. Mickie Henshall to fill the new vacancy on the Board effective as of August 15, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mickie Henshall was appointed as Director at VOLITIONRX LTD.

Action
appointed
Role
Director
Exact text from the filing
On August 15, 2022, the Board of Directors (the “ Board ”) of VolitionRx Limited (the “ Company ”), pursuant to the Company’s Bylaws, passed a resolution to increase the size of the Board to nine (9) members and appointed Ms. Mickie Henshall to fill the new vacancy on the Board effective as of August 15, 2022.
View on SEC.gov

VOLITIONRX LTD filing history →

Source: SEC EDGAR
accession 0001477932-22-006194
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.